Drug Approval | August 11, 2025
Shilpa Medicare receives approval of NorUDCA tablets for treatment of NAFLD in India
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Subscribe To Our Newsletter & Stay Updated
